Small molecule Mcl-1 inhibitors for the treatment of cancer

被引：145

作者：

Belmar, Johannes ^{[1
]}

Fesik, Stephen W. ^{[1
]}

机构：

[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA

来源：

PHARMACOLOGY & THERAPEUTICS | 2015年 / 145卷

关键词：

Mcl-1; Myeloid cell leukemia-1; Inhibitors; Small molecule; BH3-mimetic; CELL LUNG-CANCER; BCL-2 FAMILY PROTEINS; ANTI-APOPTOTIC MCL-1; BH3 MIMETIC ABT-737; TARGETING MCL-1; MELANOMA-CELLS; IMMUNOHISTOCHEMICAL ANALYSIS; BIOLOGICAL EVALUATION; RATIONAL DESIGN; RESISTANCE;

D O I：

10.1016/j.pharmthera.2014.08.003

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

The Bcl-2 family of proteins serves as primary regulators of apoptosis. Myeloid cell leukemia 1 (Mcl-1), a prosurvival member of the Bcl-2 family of proteins, is overexpressed and the Mcl-1 gene is amplified in many tumor types. Moreover, the overexpression of Mcl-1 is the cause of resistance to several chemotherapeutic agents. Thus, Mcl-1 is a promising cancer target. This review highlights the current progress on the discovery of small molecule Mcl-1 inhibitors. (C) 2014 Elsevier Inc. All rights reserved.

引用

收藏

页码：76 / 84

页数：9

相关论文

共 93 条

[1]

Abbott Laboratories, 2008, Patent No. [WO2008131000A2, 2008131000]

[2]

3-Substituted-N-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a Novel Class of Selective Mcl-1 Inhibitors: Structure-Based Design, Synthesis, SAR, and Biological Evaluation [J].

Abulwerdi, Fardokht A. ;

Liao, Chenzhong ;

Mady, Ahmed S. ;

Gavin, Jordan ;

Shen, Chenxi ;

Cierpicki, Tomasz ;

Stuckey, Jeanne A. ;

Showalter, H. D. Hollis ;

Nikoovska-Coleska, Zaneta .

JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (10) :4111-4133

[3]

The Bcl-2 apoptotic switch in cancer development and therapy [J].

Adams, J. M. ;

Cory, S. .

ONCOGENE, 2007, 26 (09) :1324-1337

[4]

Mcl-1 is a potential therapeutic target in multiple types of cancer [J].

Akgul, C. .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (08) :1326-1336

[5]

Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA [J].

Albershardt, Tina C. ;

Salerni, Bethany L. ;

Soderquist, Ryan S. ;

Bates, Darcy J. P. ;

Pletnev, Alexandre A. ;

Kisselev, Alexei F. ;

Eastman, Alan .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (28) :24882-24895

[6]

The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients [J].

Andersen, MH ;

Becker, JC ;

Straten, PT .

LEUKEMIA, 2005, 19 (03) :484-485

[7]

Mcl-1 is a key regulator of apoptosis during CNS development and after DNA damage [J].

Arbour, Nicole ;

Vanderluit, Jacqueline L. ;

Le Grand, J. Nicole ;

Jahani-Asl, Arezu ;

Ruzhynsky, Vladimir A. ;

Cheung, Eric C. C. ;

Kelly, Melissa A. ;

MacKenzie, Alexander E. ;

Park, David S. ;

Opferman, Joseph T. ;

Slack, Ruth S. .

JOURNAL OF NEUROSCIENCE, 2008, 28 (24) :6068-6078

[8]

Baell JB, 2010, FUTURE MED CHEM, V2, P1529, DOI [10.4155/fmc.10.237, 10.4155/FMC.10.237]

[9]

Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review [J].

Bajwa, Naval ;

Liao, Chenzhong ;

Nikolovska-Coleska, Zaneta .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (01) :37-55

[10]

Structural Insights into the Design of Small Molecule Inhibitors That Selectively Antagonize Mcl-1 [J].

Bernardo, Paul H. ;

Sivaraman, Thirunavukkarasu ;

Wan, Kah-Fei ;

Xu, Jin ;

Krishnamoorthy, Janarthanan ;

Song, Chun Meng ;

Tian, Liming ;

Chin, Jasmine S. F. ;

Lim, Diane S. W. ;

Mok, Henry Y. K. ;

Yu, Victor C. ;

Tong, Joo Chuan ;

Chai, Christina L. L. .

JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (05) :2314-2318

← 1 2 3 4 5 6 7 8 9 10 →